Affordable Access

deepdyve-link
Publisher Website

Practical Guidelines for Collection, Manipulation and Inactivation of SARS-CoV-2 and COVID-19 Clinical Specimens.

Authors
  • Bain, William1
  • Lee, Janet S1
  • Watson, Alan M2
  • Stitt-Fischer, Molly S3
  • 1 Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • 2 Department of Cell Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • 3 Department of Environmental Health and Safety, University of Pittsburgh, Pittsburgh, Pennsylvania.
Type
Published Article
Journal
Current protocols in cytometry
Publication Date
Jun 01, 2020
Volume
93
Issue
1
Identifiers
DOI: 10.1002/cpcy.77
PMID: 32502333
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

SARS-CoV-2 is a novel coronavirus that causes the acute respiratory disease-Coronavirus disease 2019 (COVID-19)-which has led to a global health crisis. Currently, no prophylactics or therapies exist to control virus spread or mitigate the disease. Thus, the risk of infection for physicians and scientists is high, requiring work to be conducted in Biosafety Level-3 (BSL-3) facilities if virus will be isolated or propagated. However, inactivation of the virus can enable safe handling at a reduced biosafety level, making samples accessible to a diverse array of institutions and investigators. Institutions of all types have an immediate need for guidelines that outline safe collection, handling, and inactivation of samples suspected to contain active virus. Here we provide a practical guide for physicians and researchers wishing to work with materials from patients who are COVID-19 positive or suspected positive. © 2020 Wiley Periodicals LLC. Basic Protocol 1: Practical guidelines for the safe collection and handling of specimens collected from COVID-19 and suspected COVID-19 patients Basic Protocol 2: Inactivating SARS-CoV-2. © 2020 Wiley Periodicals LLC.

Report this publication

Statistics

Seen <100 times